{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:07:34Z","timestamp":1759334854851,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jaad.2010.05.007","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T04:38:36Z","timestamp":1300336716000},"page":"791-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Is concomitant use of methotrexate and oral retinoids dangerous? A\u00a0review of the data regarding this combination"],"prefix":"10.1016","volume":"64","author":[{"given":"Alyssa D.","family":"Searles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2010.05.007_bib1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2230.1985.tb00558.x","article-title":"Methotrexate maintenance therapy and liver damage in psoriasis","volume":"10","author":"van de Kerkhof","year":"1985","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.05.007_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.1980.tb06553.x","article-title":"Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment","volume":"102","author":"Zachariae","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.007_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00128071-200001010-00003","article-title":"Risk-benefit assessment of methotrexate in the treatment of severe psoriasis","volume":"1","author":"Kuijpers","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2010.05.007_bib4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0190-9622(99)80058-9","article-title":"Effects of acitretin on the liver","volume":"41","author":"Roenigk","year":"1999","journal-title":"J Am Acad Dermatol"},{"year":"2002","series-title":"Soriatane (acitretin) [package insert]","key":"10.1016\/j.jaad.2010.05.007_bib5"},{"year":"2000","series-title":"Methotrexate [package insert]","key":"10.1016\/j.jaad.2010.05.007_bib6"},{"key":"10.1016\/j.jaad.2010.05.007_bib7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archderm.1982.01650210040015","article-title":"Methotrexate and etretinate as concurrent therapies in severe psoriasis","volume":"118","author":"Vanderveen","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.007_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archderm.1983.01650340003007","article-title":"Concurrent methotrexate and etretinate therapy for psoriasis","volume":"119","author":"Adams","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.007_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0190-9622(84)80007-9","article-title":"Treatment of generalized pustular psoriasis with etretinate (Ro 10-0359) and methotrexate","volume":"10","author":"Rosenbaum","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.007_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0190-9622(86)70009-1","article-title":"Combination therapy for psoriasis with methotrexate and etretinate","volume":"14","author":"Tuyp","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.007_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/j.1552-4604.1990.tb01877.x","article-title":"Interaction of etretinate with methotrexate pharmacokinetics in psoriatic patients","volume":"30","author":"Larsen","year":"1990","journal-title":"J Clin Pharmacol"},{"year":"2004","series-title":"Contemporary diagnosis and management of psoriasis","author":"Koo","key":"10.1016\/j.jaad.2010.05.007_bib12"},{"key":"10.1016\/j.jaad.2010.05.007_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00128071-200506060-00003","article-title":"Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?","volume":"6","author":"Thomas","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2010.05.007_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000249755","article-title":"Toxic hepatitis due to combination therapy with methotrexate and etretinate in psoriasis","volume":"167","author":"Beck","year":"1983","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2010.05.007_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0190-9622(09)80252-1","article-title":"Cholestatic hepatitis occurring shortly after etretinate therapy","volume":"31","author":"Kano","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"5 pt 2","key":"10.1016\/j.jaad.2010.05.007_bib16","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0190-9622(93)70117-C","article-title":"Retinoid hepatitis","volume":"28","author":"Sanchez","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"6 pt 1","key":"10.1016\/j.jaad.2010.05.007_bib17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0190-9622(97)80281-2","article-title":"Adult pityriasis rubra pilaris: a 10-year case series","volume":"36","author":"Clayton","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.007_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/09546630701759579","article-title":"Concurrent use of methotrexate and acitretin revisited","volume":"19","author":"Lowenthal","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2010.05.007_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/120347540400800602","article-title":"The frequent use of oral retinoids in combination with other treatments for psoriasis: a retrospective analysis","volume":"8","author":"Hu","year":"2004","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2010.05.007_bib20","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1440-1746.2001.02644.x","article-title":"Role of non-alcoholic steatohepatitis in methotrexate induced liver injury","volume":"16","author":"Langman","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2010.05.007_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/rheumatology\/kep023","article-title":"Liver fibrosis in patients with psoriasis and psoriatic arthritis on long\/term, high cumulative dose methotrexate therapy","volume":"48","author":"Lindsay","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2010.05.007_bib22","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/rheumatology\/kep238","article-title":"Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy","volume":"48","author":"Boffa","year":"2009","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221000561X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221000561X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:20:31Z","timestamp":1759270831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221000561X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S019096221000561X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2010.05.007","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is concomitant use of methotrexate and oral retinoids dangerous? A\u00a0review of the data regarding this combination","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2010.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}